DR. SCOTT BENNETT SCHNEIDER, M.D.
PEWAUKEE, WI
What does SCOTT SCHNEIDER research?
Dr. Schneider studies the effectiveness of treatments for serious health conditions, particularly cancers and chronic respiratory diseases. For example, he has researched a new drug combination for small cell lung cancer and the long-term effects of medication for chronic rhinosinusitis with nasal polyps. In the realm of mental health, he investigates how patient expectations influence the success of anxiety therapies. His work also delves into the relationship between vascular issues and brain function, and ethical considerations surrounding medical nutrition therapy.
Key findings
- In a study on extensive-stage small cell lung cancer, only 12.6% of 517 patients showed long-term positive responses to treatment with atezolizumab and chemotherapy, with an average survival of 11.3 months.
- In patients with unilateral carotid artery stenosis, a significant decrease in brain activity coherence at around 0.1 Hz was found, highlighting the connection between blood flow changes and brain function.
- 28.7% of chronic rhinosinusitis patients met 2021 guidelines for biologic treatments, which could improve their quality of life significantly.
- Over a span of up to 4.5 years, dupilumab therapy reduced the average number of other medications needed by chronic rhinosinusitis patients from 1.6 to lower levels.
- In research on exposure therapy for anxiety, negative patient expectations were linked to poorer outcomes, demonstrating how mindset can impact treatment efficacy.
Frequently asked questions
- Does Dr. Schneider study cancer treatments?
- Yes, Dr. Schneider researches various treatments for cancers, particularly small cell lung cancer, and their effectiveness.
- What are the effects of dupilumab in chronic rhinosinusitis patients?
- Dupilumab significantly reduces the need for other medications in chronic rhinosinusitis patients, improving their treatment experience.
- How does patient expectation affect anxiety treatment?
- Dr. Schneider found that negative expectations can lead to worse treatment outcomes in patients undergoing exposure therapy for anxiety.
- Is Dr. Schneider's work relevant to mental health?
- Yes, he studies the impact of therapies on anxiety disorders, exploring how factors like patient expectations influence treatment success.
- What insights does Dr. Schneider provide on medical nutrition therapy?
- He focuses on ethical aspects, ensuring that nutrition therapies align with patient needs and medical goals.
Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.